Patents Represented by Attorney Kathleen R. Terry
  • Patent number: 7553817
    Abstract: The present invention relates to compositions for supplementing the diet of subjects suffering from cardiovascular or peripheral vascular disease or those at risk for such conditions. Ribose is given alone or in combination with one or a combination of vasodilators, nutrients and vitamins. Preferred vitamins include Vitamins C, B6, B12 and folic acid. Preferred nutrients include glutamine and glucose.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: June 30, 2009
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
  • Patent number: 7094762
    Abstract: The present invention relates to methods and compositions comprising ribose and maleate for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially useful for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.
    Type: Grant
    Filed: December 27, 2003
    Date of Patent: August 22, 2006
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
  • Patent number: 6854465
    Abstract: A face mask support for CPAP comprising a hemispheric cap with biasing means support at the medial line of the head. The circumferential edge of the cap extends from the high forehead to below the inion protrusion at the nape of the neck. A biasing means which is preferably of a length of spring steel is formed so as to extend from the biasing means support to form a loop around a face mask. The biasing means may be adjusted to accommodate facial configurations and to vary the pressure with which the face mask is apposed to the face. In an alternative embodiment, the support is open and is comprised of a circumferential band extending from the middle of the forehead to below the inion protrusion and a medial band extending along the medial line of the head and connecting to the circumferential band at the middle of the forehead and below the inion protrusion.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: February 15, 2005
    Assignee: AEIOMed, Inc.
    Inventors: Steven S. Bordewick, H. Stephen Quinn
  • Patent number: 6790603
    Abstract: Blood platelets stored in an isotonic, balanced salt solution under standard storage conditions retain function after ten days of storage when micormolar or nanomolar amounts of pentose are added to the solution. The preferred pentoses are D-Ribose, xylulose-5-phosphate and the pentose-related alcohol xylitol.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: September 14, 2004
    Assignee: Bioenergy, Inc.
    Inventors: Daniel G. Ericson, John St. Cyr
  • Patent number: 6703370
    Abstract: The present invention relates to methods and compositions comprising ribose for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially suitable for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: March 9, 2004
    Assignee: Bioenergy, Inc.
    Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
  • Patent number: 6692473
    Abstract: The invention is a dual lumen, adjustable cannula assembly which comprises an inner cannula which is moveable within an outer cannula. Each cannula has openings for fluid passage. The assembly may be placed at any region within a body cavity such as the peritoneal cavity, the vena cava, veins or arteries. The inner cannula can be advanced beyond the position of the cannula assembly so as to communicate with a region of the cavity different from that with which the outer cavity communicates.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: February 17, 2004
    Inventors: John A. St. Cyr, J. Michael Holton, Theodore C. Kelly, Linda M. Shecterle
  • Patent number: 6689262
    Abstract: An oxygen emitter which is an electrolytic cell is disclosed. When the anode and cathode are separated by a critical distance, very small microbubbles and nanobubbles of oxygen are generated. The hydrogen forms bubbles at the cathode, which bubbles rise to the surface. The very small oxygen bubbles remain in suspension, forming a solution supersaturated in oxygen. The electrodes may be a metal or oxide of at least one metal selected from the group consisting of ruthenium, iridium, nickel, iron, rhodium, rhenium, cobalt, tungsten, manganese, tantalum, molybdenum, lead, titanium, platinum, palladium and osmium or oxides thereof. The electrodes may be formed into open grids or may be closed surfaces. The most preferred cathode is a stainless steel mesh. The most preferred mesh is a {fraction (1/16)} inch grid. The most preferred anode is platinum and iridium oxide on a support. A preferred support is titanium. Models suitable for different uses are disclosed.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: February 10, 2004
    Assignee: Aqua Innovation, Inc.
    Inventor: James Andrew Senkiw
  • Patent number: 6663859
    Abstract: D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral administration of D-Ribose. Methods are also provided for the enhancement of the immune response in isolated leukocytes. Leukocytes are cultured ex vivo in the presence of D-Ribose and transfused into a patient in need of leukocyte augmentation.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: December 16, 2003
    Assignees: Bioenergy, Inc., University of Florida
    Inventors: Susan S. Percival, Robin J. Henken, John St. Cyr, Clarence A. Johnson, Terri L. Butler
  • Patent number: 5788641
    Abstract: A device capable of providing non-invasive, accurate estimates of central venous pressure. This diagnostic device is particularly useful with patients suffering from cardiac disease.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: August 4, 1998
    Assignee: Research Foundation of State University of New York at Buffalo
    Inventors: Dennis C. Policastro, Robert E. Mates, Kenneth Peebles